Denali Therapeutics shares owned by Springbok Capital Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Springbok Capital Management
from 13F filings
Historical chart of Springbok Capital Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Springbok Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $213k | 10k | 20.63 |
| 2023-06-30 | $314k | 11k | 29.51 |
| 2023-03-31 | $261k | 11k | 23.04 |
| 2022-12-31 | $204k | 7.3k | 27.81 |
| 2021-12-31 | $429k | 9.6k | 44.64 |
| 2021-09-30 | $303k | 6.0k | 50.40 |
| 2021-06-30 | $391k | 5.0k | 78.47 |
| 2020-12-31 | $247k | 3.0k | 83.73 |
| 2020-09-30 | $326k | 9.1k | 35.82 |
| 2020-06-30 | $264k | 11k | 24.20 |
| 2019-03-31 | $98k | 4.2k | 23.17 |
| 2018-12-31 | $41k | 2.0k | 20.74 |
More positions owned by Springbok Capital Management
View all positions for Springbok Capital Management